These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30373594)

  • 21. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
    Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
    Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.
    Zu Y; Wang J; Ping W; Sun W
    Mol Med Rep; 2018 Feb; 17(2):2384-2392. PubMed ID: 29207086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway.
    Zhang X; Wang Q; Wang X; Chen X; Shao M; Zhang Q; Guo D; Wu Y; Li C; Wang W; Wang Y
    Biomed Pharmacother; 2019 Apr; 112():108599. PubMed ID: 30798134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
    Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
    Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways.
    Pan TL; Wang PW; Hung YC; Huang CH; Rau KM
    Proteomics; 2013 Dec; 13(23-24):3411-23. PubMed ID: 24167031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anti-tumor activity of the tanshinone IIA against SKOV3 cells.
    Huang J; Lin H; Hong Y
    Nat Prod Res; 2016 Aug; 30(16):1844-6. PubMed ID: 26252372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW; Wen F
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.
    Liu J; Zhang C; Liu S; Wang X; Wu X; Hao J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):365-374. PubMed ID: 36374307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction.
    Huang ST; Huang CC; Huang WL; Lin TK; Liao PL; Wang PW; Liou CW; Chuang JH
    Sci Rep; 2017 Jan; 7():40382. PubMed ID: 28106052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.
    Kim JY; Song JJ; Kwon BM; Lee JD
    Mol Med Rep; 2015 Sep; 12(3):4604-4609. PubMed ID: 26080622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
    Su CC
    Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
    Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
    Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP‑2 and NF‑κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease.
    Jiang P; Li C; Xiang Z; Jiao B
    Mol Med Rep; 2014 Aug; 10(2):689-94. PubMed ID: 24859152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
    He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
    Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
    Chen J; Shi DY; Liu SL; Zhong L
    Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.